Dalton has more than 30 years of healthcare leadership experience. He most recently was chair and CEO of National Dentex Labs. He also has leadership experience from Baxter, Allegiance Healthcare and Cardinal Health, and was the founder and CEO of Devicor Medical Products.
“I am thrilled to join this exceptional team and continue the progress David has already championed,” Daulton said. “As an end-to-end MedTech service provider, Veranex is clearly poised for an exciting future. My background — including experience building two large global healthcare businesses — has afforded me a solid understanding of how to knit a variety of cultures together into a powerful, unified business. I look forward to working closely with the team to build on Veranex’s role as a leader in MedTech innovation, providing comprehensive solutions to our customers and continuing to raise the industry standard for both quality and speed to market.”
Dockhorn, who previously served as Veranex’s CEO, is assuming the newly created role of chief operating officer. He will support Dalton in business integration and in building the organizational structure needed to support the company’s growing footprint.
“I am proud of the company we are building and the impact we are making every day with our customers,” Dockhorn said. “Our global team has worked to build a company that uniquely addresses the whole suite of MedTech customer needs — from medical device discovery to invention, manufacturing, preclinical, clinical/regulatory, market launch, and commercial — allowing our clients to work on a global scale. I am excited to strengthen our impact by focusing on building the operational teams that support organic growth as we continue to build out our capabilities and enhance our operations, while Tom focuses on leading the organization and helping it expand.”